Form D · Biotechnology
KIKA MEDICAL INTERNATIONAL CO
Boston, MA · CIK 0001423366
Offering snapshot reported Aug 14, 2009 · SEC filing
- Reported sold
- $850K Offering amount: $2.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 31, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 14, 2009 | Initial | $850,000 | No comparison | 2 | SEC filing |
| Apr 15, 2009 | Initial | $496,000 | No comparison | Not reported | SEC filing |
| Sep 22, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-113086
Source: Form D, filed Aug 14, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric Archambeau | Director |
| Linda Beneze | Director, Executive |
| Nicolas Dubost | Executive |
| William Gedale | Director |
| Gerard Moufflet | Director |
| Georg Nebgen | Director |
| Jean Paul Ortelli | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
21 Milk Street 5th Floor
Boston, MA, 02109
Boston, MA, 02109